SFOSFOTCHealthcare · Drug Manufacturers - Specialty & Generic

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

$2.42+0.00%(+$0.00)

TickerSpark Score

61/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SFOSF research report →

52-Week Range43% of range

Low $1.62

Current $2.42

High $3.50

Companywww.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co. , Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally.

CEO: Yi Liu
IPO: 2014
Employees: 40,557
HQ: Shanghai, CN

Price Chart

+24.10% · this period

Valuation

Market Cap: $6.42B
P/E: 18.39
P/S: 1.51
P/B: 1.30
EV/EBITDA: 15.94
Div Yield: 1.32%

Profitability

Gross Margin: 49.44%
Op Margin: 9.63%
Net Margin: 8.22%
ROE: 7.19%
ROIC: 3.15%

Growth & Income

Revenue: $40.43B · -1.56%
Net Income: $3.28B · 18.55%
EPS: $1.26 · 21.15%
Op Income: $2.54B
FCF YoY: 1045.04%

Performance & Tape

52W High: $3.50
52W Low: $1.62
50D MA: $2.58
200D MA: $2.85
Beta: 0.41
Avg Volume: 32

Get TickerSpark's AI analysis on SFOSF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime